Preclinical Imaging: Grants and Publications

Selected Publications Made Possible by Preclinical Imaging

We have contributed to many high quality publications. For more publications, contact us.

• Ying Z, Beronja S. Embryonic barcoding of equipotent mammary progenitors functionally identifies breast cancer drivers. Cell Stem Cell. 2020;26(3):403-419.e4. doi: 10.1016/j.stem.2020.01.009
  
• Jia D, Augert A, Kim D-W et al. Crebbp loss drives small cell lung cancer and increases sensitivity to HDAC inhibition. Cancer Discov. 2018;8(11):1422-1437. doi: 10.1158/2159-8290.CD-18-0385
• Hudecek M, Sommermeyer D, Kosasih P et al. The nonsignaling extracellular spacer domain of chimeric antigen receptors is decisive for in vivo antitumor activity. Cancer Immunol Res. 2015;3(2):125-35. doi: 10.1158/2326-6066.CIR-14-0127
• Stromnes I, Schmitt T, Hulbert A et al. T cells engineered against a native antigen can surmount immunologic and physical barriers to treat pancreatic ductal adenocarcinoma. Cancer Cell. 2015;28(5):638-652. doi: 10.1016/j.ccell.2015.09.022
• Provenzano PP, Cuevas C, Chang AE et al. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. Cancer Cell. 2012;21(3):418-429. doi: 10.1016/j.ccr.2012.01.007